6-minute Pegboard Ring Test in Patients with Scleroderma

Launched by YASEMIN GEDIKLI · Sep 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a test called the 6-minute pegboard and ring test (6PBRT) to see if it is a reliable way to measure how well patients with systemic sclerosis (scleroderma) can use their hands and arms. The main goal is to find out if this test can accurately assess the strength and function of upper body movements in people with this condition. Participants will perform the test twice, with a break in between, and other measurements related to muscle strength and oxygen levels will also be taken.

To be eligible for this study, participants must be between 18 and 75 years old and have been diagnosed with systemic sclerosis. They should be in stable health and able to understand and cooperate with the tests. However, individuals with certain conditions, like severe joint problems or infections, or those who are pregnant or have other serious diseases, cannot participate. This trial is not yet recruiting participants, but it aims to gather important information that could help improve care for people living with scleroderma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being between the ages of 18-75
• • 2013 To be diagnosed with systemic sclerosis according to ACR/EULAR classification criteria
• • Being clinically stable
• • Ability to adapt to tests (visual, cognitive, cooperative)
• Exclusion Criteria:
• • Those with neurological and/or musculoskeletal problems that may affect the work
• • Presence of severe joint contracture or painful ulcers that may affect muscle strength measurement and walking
• • Presence of severe infection or sepsis
• • Being diagnosed with a known additional rheumatologic disease
• • Any stage of cancer
• • Pregnant or breastfeeding